Should the FDA Get Tougher on Investigational Review Boards?
The FDA says that investigational review boards (IRBs) aren’t required to collect a statement of investigator assurance from studies they preside over.
Bottom-Up Healthcare Reform
One of our major problems with healthcare reform is that we are doing it from the top down.
The FDA’s Action Plan Demands Some Industry Action, Too
The U.S. Food and Drug Administration (FDA) has a “Plain Jane” version of its Pharmaceuticals FY 2015 Action Plan. In this article, however, let’s look at some interesting wrinkles not necessarily contained in the document.
Three Reasons Hospitals Resist Investing in Quality
Why is it easier for many hospitals to justify investing in capital equipment, new buildings, and service lines rather than in quality improvement? There are three major reasons.